Platelets and antiplatelet therapy in ischemic heart disease
- 28 February 1986
- journal article
- clinical trial
- Published by Elsevier in Current Problems in Cardiology
- Vol. 11 (2) , 72-136
- https://doi.org/10.1016/0146-2806(86)90018-6
Abstract
No abstract availableFunding Information
- American Heart Association
- National Heart, Lung, and Blood Institute
This publication has 89 references indexed in Scilit:
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Thromboxane A2in Vasotonic Angina PectorisNew England Journal of Medicine, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- The FDA's Critique of the Anturane Reinfarction TrialNew England Journal of Medicine, 1980
- Acute Coronary Insufficiency — Coronary Occlusion after Intermittent Ischemic AttacksNew England Journal of Medicine, 1980
- Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery BypassNew England Journal of Medicine, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977